Promise Of A New Day For Rx-To-OTC Switch Ruled 2012 In “The Tan Sheet”
This article was originally published in The Tan Sheet
Executive Summary
The most popular stories in “The Tan Sheet” during 2012 dealt with FDA’s nonprescription safe use regulatory extension initiative, as well as planned switches by Pfizer and Merck. In dietary supplements, coverage of firms struggling with GMPs and congressional threats to DSHEA drew the most interest.